{"organizations": [], "uuid": "b6fee2dcd25aff498a056c86b0758137ea13c6b9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-intellipharmaceutics-announces-us/brief-intellipharmaceutics-announces-us-1-8-mln-registered-direct-offering-idUSFWN1R10TS", "country": "US", "domain_rank": 408, "title": "BRIEF-Intellipharmaceutics Announces Us$ 1.8 mln Registered Direct Offering‍​", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-19T21:10:00.000+02:00", "replies_count": 0, "uuid": "b6fee2dcd25aff498a056c86b0758137ea13c6b9"}, "author": "", "url": "https://www.reuters.com/article/brief-intellipharmaceutics-announces-us/brief-intellipharmaceutics-announces-us-1-8-mln-registered-direct-offering-idUSFWN1R10TS", "ord_in_thread": 0, "title": "BRIEF-Intellipharmaceutics Announces Us$ 1.8 mln Registered Direct Offering‍​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "sec", "sentiment": "none"}, {"name": "intellipharmaceutics international inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 19, 2018 / 7:13 PM / Updated 9 minutes ago BRIEF-Intellipharmaceutics Announces Us$ 1.8 mln Registered Direct Offering‍​ Reuters Staff March 19 (Reuters) - Intellipharmaceutics International Inc: * INTELLIPHARMACEUTICS ANNOUNCES US$ 1.8 MILLION REGISTERED DIRECT OFFERING‍​ * INTELLIPHARMACEUTICS INTERNATIONAL-OFFERING OF 3 MILLION COMMON SHARES AT PURCHASE PRICE OF US$0.60 PER SHARE IN A REGISTERED DIRECT OFFERING - SEC FILING‍​ * INTELLIPHARMACEUTICS INTERNATIONAL- THE OFFERING IS IN ADDITION TO OFFERING FOR GROSS PROCEEDS OF ABOUT US$3.5 MILLION WHICH WAS PREVIOUSLY ANNOUNCED Source text - bit.ly/2G7EaYw Further company coverage:", "external_links": [], "published": "2018-03-19T21:10:00.000+02:00", "crawled": "2018-03-19T21:23:47.002+02:00", "highlightTitle": ""}